Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
Why now
Thesis: Opinion piece on turnaround and pharma wins
Catalyst to watch: Upcoming earnings and drug data
Main risk: Commentary may not reflect results
Why it matters
Investing Club commentary flags Starbucks turnaround and Lilly wins but is opinion, not data.
Details
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Related assets & topics
Eli Lilly · LLYSources
- cnbc · 2026-09-24 19:06 UTC